AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11514117
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (with and without progestogens)
Trial: 9022538
Drug: OKG bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OKG bolus (10 g; n = 13)
Trial: 9022538
Drug: Continuous gastric
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous gastric infusion of OKG (10, 20, or 30 g/d over 21 h; n = 13)
Trial: 7528032
Drug: Ovarian ablation
RxNorm normalized name: modified Vaccinia Ankara-Bavarian Nordic Injection [Jynneos]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ovarian ablation (surgical or radiotherapeutic ablation, LH-RH agonists)
Trial: 7528032
Drug: Ovarian ablation
RxNorm normalized name: modified Vaccinia Ankara-Bavarian Nordic Injection [Jynneos]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ovarian ablation (adjuvant therapy)
Trial: 31756117
Drug: 30-μg ethinylestradiol/3-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-μg ethinylestradiol/3-mg drospirenone (EE/DRSP)
Trial: 31756117
Drug: 30-μg ethinylestradiol/2-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-μg ethinylestradiol/2-mg chlormadinone acetate (EE/CMA)
Trial: 28735202
Drug: Wii Fit™
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wii Fit™ exercise therapy
Trial: 20429697
Drug: Combined potassium
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined potassium and sodium channel blocking agent for conversion of atrial fibrillation
Trial: 19281063
Drug: Biscuits (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biscuits (100 mg IF aglycones/two servings)
Trial: 19281063
Drug: Cereal bars
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cereal bars (100 mg IF aglycones/two servings)
Trial: 10190392
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 400 microg + vitamin B12 500 microg + vitamin B6 12.5 mg
Trial: 10190392
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 1 mg + vitamin B12 500 microg + vitamin B6 12.5 mg
Trial: 2310652
Drug: Dilevalol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol (200 mg or 400 mg)
Trial: 17531571
Drug: Binodenoson 0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binodenoson 0.3, 0.5, or 1 microg/kg/min infusion
Trial: 17531571
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of binodenoson
Trial: 11336101
Drug: Fluvastatin extended-release
RxNorm normalized name: Fluvastatin Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin extended-release 80 mg
Trial: 11336101
Drug: Fluvastatin extended-release
RxNorm normalized name: Fluvastatin Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin extended-release 160 mg
Trial: 1273209
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg delta9-tetrahydrocannabinol (THC)
Trial: 21849285
Drug: Delayed antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed antiretroviral therapy
Trial: 21849285
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of abacavir-lamivudine-zidovudine concurrent with tuberculosis therapy
Trial: 19437617
Drug: Topical phenylephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical phenylephrine 10% with intracameral lidocaine 1%
Trial: 19437617
Drug: Topical cyclopentolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclopentolate 1% and phenylephrine 10% with intracameral lidocaine 1%
Trial: 17666348
Drug: Tangshenqing (TSQ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tangshenqing (TSQ) combined with basic treatment
Trial: 25384603
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no NAC treatment)
Trial: 11144399
Drug: Cefdinir 7
RxNorm normalized name: Cefdinir
DrugBank: Cefdinir (DB00535)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefdinir 7 mg/kg b.i.d.
Trial: 9131324
Drug: Amoxicillin/clavulanate 13.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 13.3 mg/kg t.i.d.
Trial: 19775500
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of cannabidiol (CBD)
Trial: 19775500
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Delta 9‐tetrahydrocannabinol (Delta 9‐THC)
Trial: 18403122
Drug: Intrathecal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal fentanyl (27.4 microg ED(50) in Group A, 12.8 microg ED(50) in Group G)
Trial: 14967373
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg p.o. t.i.d. for 6 months
Trial: 205382
Drug: Calcitriol (1,25(OH)2D3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol (1,25(OH)2D3) at a mean dose of 0.579 microgram/day for 3 months
Trial: 21857969
Drug: Pharmaceutical intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmaceutical intervention in a randomized clinical trial of pharmaceutical care
Trial: 9219204
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg BID (combined beta 1, beta 2-antagonist)
Trial: 7957426
Drug: IVGG therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVGG therapy
Trial: 7957426
Drug: Low-dose PTX
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose PTX and IVGG combination therapy (10 mg/kg per day)
Trial: 7957426
Drug: High-dose PTX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose PTX and IVGG combination therapy (20 mg/kg per day)
Trial: 25812826
Drug: Client-Centered Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client-Centered Therapy (CCT)
Trial: 12680791
Drug: Adjuvant whole
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant whole brain radiation therapy (WBRT) with focal treatment (stereotactic radiosurgery or conventional surgery)
Trial: 12680791
Drug: Focal treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal treatment (stereotactic radiosurgery or conventional surgery)
Trial: 8857326
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (TNS)
Trial: 26729760
Drug: IR dl‐MPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR dl‐MPH (0.3 mg/kg)
Trial: 26729760
Drug: IR d‐MPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR d‐MPH (0.15 mg/kg)
Trial: 22569045
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine after Listerine mouthwash
Trial: 7557866
Drug: UDCA/MTX (Ursodeoxycholic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA/MTX (Ursodeoxycholic acid 13 to 15 mg/kg/d and Methotrexate 0.25 mg/kg/wk)
Trial: 388402
Drug: Tienilic acid
RxNorm normalized name: Tienilic acid
DrugBank: Tienilic acid (DB04831)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tienilic acid 250 mg once and twice daily
Trial: 388402
Drug: Hydrochlorothiazide 50
RxNorm normalized name: hydrochlorothiazide 50 MG
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 50 mg once and twice daily
Trial: 31722679
Drug: Multimodal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal analgesia with ropivacaine wound infiltration and intravenous flurbiprofen axetil
Trial: 18042869
Drug: Injection-infusion with
RxNorm normalized name: Marcaine with Epinephrine Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection-infusion with levobupivacaine
Trial: 18042869
Drug: Placebo injection-infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injection-infusion
Trial: 10335995
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron (3 x 100 mg Fe2+ per day for 5 weeks before operation)
Trial: 10335995
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron (200 mg Fe3+ after each donation with initial i.v. iron supplementation for hemoglobin under 15 g/dL)
Trial: 10335995
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no iron medication)
Trial: 8565027
Drug: BDP AQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP AQ Forte (0.084%) nasal spray 336 micrograms once daily
Trial: 973959
Drug: Propranolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (100 mg)
Trial: 25931216
Drug: Stopping immunosuppressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopping immunosuppressive agents (SD group)
Trial: 25931216
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (did not stop immunosuppressive drugs)
Trial: 8882471
Drug: Ranitidine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine and antacid (group 2)
Trial: 8882471
Drug: H2-receptor antagonist
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonist and antacid (group 3, H. pylori-negative patients)
Trial: 6669871
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (rest in splints, non‐steroidal anti‐inflammatory drugs, gold or anti‐malaria agent) for 4-5 months
Trial: 6669871
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (non-surgical treatment)
Trial: 6669871
Drug: All patients
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All patients (surgical and conservative treatment)
Trial: 29405368
Drug: Proactive telephone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive telephone support (daily calls for up to 14 days after discharge)
Trial: 12096707
Drug: Nurse-managed smoking
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-managed smoking cessation program including physician advice, bedside education and counseling, take-home materials, nicotine replacement therapy, and post-discharge counseling calls.
Trial: 26830468
Drug: DAS181 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAS181 (10 mg administered via dry particle inhaler on 3 consecutive days)
Trial: 25332321
Drug: Fish-oil supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil supplementation (1.5 g LC n-3 PUFAs/d)
Trial: 22302719
Drug: Letrozole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (10 mg daily for 3 days)
Trial: 1491396
Drug: oral Ca
RxNorm normalized name: coral calx
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral Ca (control)
Trial: 30332482
Drug: Sufentanil 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 1.5 μg/kg
Trial: 30332482
Drug: Sufentanil 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 2.0 μg/kg
Trial: 30332482
Drug: Sufentanil 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 2.5 μg/kg
Trial: 27207411
Drug: DDS-1 strain
RxNorm normalized name: Haemagglutinin-strain B
DrugBank: Haemagglutinin-strain B (DB15482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDS-1 strain of Lactobacillus acidophilus (1 dose daily for 4 weeks)
Trial: 22331758
Drug: Bicalutamide 50-mg
RxNorm normalized name: bicalutamide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide 50-mg tablets (test formulation)
Trial: 20558755
Drug: L-NAME infusion
RxNorm normalized name: L-NAME
DrugBank: N-omega-nitro-L-arginine methyl ester (DB12750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME infusion
Trial: 8536087
Drug: Daily use
RxNorm normalized name: ALCOHOL 75 mL in 100 mL TOPICAL GEL [Better For Daily Use EAAE Disinfectant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily use of xylitol chewing gum (study group)
Trial: 8536087
Drug: Daily use
RxNorm normalized name: ALCOHOL 75 mL in 100 mL TOPICAL GEL [Better For Daily Use EAAE Disinfectant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily use of xylitol chewing gum (control group)
Trial: 29906570
Drug: FOND-O (Fosaprepitant,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOND-O (Fosaprepitant, Ondansetron, Dexamethasone + Olanzapine 10 mg)
Trial: 25414047
Drug: PS+PA (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PS+PA (300 mg PS + 240 mg PA/day)
Trial: 27104905
Drug: mHealth accelerometer-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth accelerometer-based physical activity prescription
Trial: 22162508
Drug: valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: valproic acid (300 mg bid) with early or late addition of lacosamide (200 mg bid)
Trial: 22162508
Drug: lacosamide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lacosamide (200 mg bid) with early or late addition of valproic acid (300 mg bid)
Trial: 17346530
Drug: Antibiotics (metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (metronidazole plus azithromycin)
Trial: 7942354
Drug: Mefloquine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine (750 mg given immediately, followed by 500 mg 6 h later) with tetracycline (250 mg four times daily)
Trial: 7942354
Drug: Quinine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine (600 mg every 8 h for seven days) with tetracycline (250 mg four times daily)
Trial: 31415392
Drug: Individualized occlusal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized occlusal splint therapy applied during day‐ and nighttime plus usual care (n=30)
Trial: 24065294
Drug: Combination exercise
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination exercise training (aerobic, strength, and stretching exercise trainings) 3 days per week for 4 weeks (12 workouts total)
Trial: 17928625
Drug: Candesartan (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (32 mg daily)
Trial: 17928625
Drug: Quinapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (20 mg daily)
Trial: 21239359
Drug: Abacavir 300
RxNorm normalized name: abacavir 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir 300 mg twice daily
Trial: 11901939
Drug: Diuretic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic and ACE inhibitor combination
Trial: 9853849
Drug: Org 37462
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 37462 (ganirelix) 0.0625 mg
Trial: 9853849
Drug: Org 37462
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 37462 (ganirelix) 0.125 mg
Trial: 9853849
Drug: Org 37462
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 37462 (ganirelix) 0.25 mg
Trial: 9853849
Drug: Org 37462
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 37462 (ganirelix) 2 mg
Trial: 9853849
Drug: Org 37462
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 37462 (ganirelix) 1 mg
Trial: 3354872
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg preservative-free morphine sulfate in 0.2 ml solution added to hyperbaric spinal bupivacaine
Trial: 3354872
Drug: 0.2 ml
RxNorm normalized name: isopropyl alcohol 0.2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 ml saline added to bupivacaine (Control)
Trial: 26415375
Drug: Levofloxacin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (750 mg once daily for 10 days)
Trial: 24091269
Drug: Early removal
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early removal group (drainage < 300 ml/24 h), n = 41
Trial: 24091269
Drug: Traditional management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional management group (drainage < 100 ml/24 h), n = 29
Trial: 22044691
Drug: Docetaxel addition
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel addition to adjuvant anthracycline-based chemotherapy
Trial: 19070056
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (20 mg day(‐1))
Trial: 19070056
Drug: Iron +
RxNorm normalized name: Celebrate Iron + C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron + Zinc supplementation (20 mg of each day(‐1))
Trial: 7488417
Drug: Granisetron plus
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron plus hydroxyzine hydrochloride (group G/H)
Trial: 31607719
Drug: Edaravone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone treatment
Trial: 27160841
Drug: ICU Nurse-Physician
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ICU Nurse-Physician Questionnaire (ICU N-P-Q) administered to physicians and nurses
Trial: 25115761
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH; reviparin)
Trial: 9385125
Drug: Beclomethasone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone (200 microg twice daily)
Trial: 17990465
Drug: Chemotherapy of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy of DCF regimen combined with Chinese herbal medicine
Trial: 17990465
Drug: Chemotherapy of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy of DCF regimen alone
Trial: 3001780
Drug: 1‐g marihuana
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1‐g marihuana cigarette containing 1.83% delta 9‐tetrahydrocannabinol (THC)
Trial: 29616749
Drug: Magnetic therapy:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetic therapy: 10 mT, 50 Hz
Trial: 29616749
Drug: Placebo magnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo magnetic therapy
Trial: 23926420
Drug: Intravenous dihydroergotamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dihydroergotamine (IV DHE)
Trial: 17158412
Drug: Garlic powder
RxNorm normalized name: Garlic Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic powder (2.1 g/d)
Trial: 9146778
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg for 3 consecutive days each week
Trial: 18685511
Drug: Synbiotic formulation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic formulation C (5 probiotics and FOS)
Trial: 18685511
Drug: Synbiotic formulation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic formulation D (5 probiotics and GOS)
Trial: 14525568
Drug: Topical anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anti-inflammatory gel (NSAID)
Trial: 10655976
Drug: Spread enriched
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spread enriched with free soyabean-oil sterols (0.8 g/d)
Trial: 1304727
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg of oral triazolam and 0.75 mg of intrathecal phenylephrine
Trial: 6089652
Drug: Intranasal human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal human interferon-alpha 2 (HuIFN-alpha 2) 10(7) IU/day
Trial: 26362259
Drug: Teacher Help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Teacher Help for ADHD treatment group
Trial: 27374361
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy (AlGaAs infrared laser 808 nm)
Trial: 27374361
Drug: Mock laser
RxNorm normalized name: mockernut extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mock laser therapy (device powered off)
Trial: 25140469
Drug: Left internal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left internal thoracic artery (LITA) for LAD and free right internal thoracic artery (RITA) for circumflex in Group-1 (G-1)
Trial: 22221980
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (three monthly workshops promoting healthy behaviors)